Characterizing Enoxaparin’s Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population
-
Published:2024-07
Issue:7
Volume:63
Page:999-1014
-
ISSN:0312-5963
-
Container-title:Clinical Pharmacokinetics
-
language:en
-
Short-container-title:Clin Pharmacokinet
Author:
Carreño Fernando O.ORCID, Gerhart Jacqueline G.ORCID, Helfer Victória E.ORCID, Sinha JaydeepORCID, Kumar Karan R.ORCID, Kirkpatrick CarlORCID, Hornik Christoph P.ORCID, Gonzalez DanielORCID, Benjamin Daniel K., Zimmerman Kanecia, Kennel Phyllis, Alderman Cheryl, Sund Zoe, Opel Kylie, Beci Rose, Hornik Chi Dang, Kearns Gregory L., Laughon Matthew, Paul Ian M., Sullivan Janice, Wade Kelly, Delmore Paula, West Leanne, Abdel-Rahman Susan, Anand Ravinder, Payne Elizabeth, Chen Lily, Simone Gina, O’Connor Kathleen, Cermak Jennifer, Taylor Lawrence, Green Thomas, Benjamin Danny, Taylor-Zapata Perdita, Wade Kelly, Kearns Greg, Anand Ravinder, Paul Ian, Autmizguine Julie, Capparelli Edmund, Zimmerman Kanecia, Greenberg Rachel, Alderman Cheryl, Green Terren, Atz Andrew, Lenert Leslie, Clark John, Chundru Kalyan, Bendel Catherine, Harvey Brian, Grillo Sonya, Chan Francis, Fan Stephanie, Downes Kevin, Grundmeier Robert, Ramos Mark, O’Connor Shawn, Fogel Benjamin, Gipson Debbie, Attala Samara, Eickstadt Richard, Kaleba Erin, Liamini Don, Estill Jamie, Jared Jeremy, Bow Peter, Laughon Matt, Talbert Jennifer, Clark Cindy, Miller Michael, Muller William, Smith Michael, Sullivan Janice, Heilman Steve, Singh K. P., Vuyyuri Satish, Schwitters Jeff, Stone Don,
Funder
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Lovenox [product monograph] [Internet]. 2018. Available from https://pdf.hres.ca/dpd_pm/00047708.PDF 2. Monagle P, Chan AKC, Goldenberg NA, Ichord RN, Journeycake JM, Nowak-Göttl U, et al. Antithrombotic therapy in neonates and children. Chest. 2012;141:e737S-e801S. 3. Schobess R, Düring C, Bidlingmaier C, Heinecke A, Merkel N, Nowak-Göttl U. Long-term safety and efficacy data on childhood venous thrombosis treated with a low molecular weight heparin: an open-label pilot study of once-daily versus twice-daily enoxaparin administration. Haematologica. 2006;91:1701–4. 4. Dix D, Andrew M, Marzinotto V, Charpentier K, Bridge S, Monagle P, et al. The use of low molecular weight heparin in pediatric patients: a prospective cohort study. J Pediatr. 2000;136:439–45. 5. Anticoagulation T, Leung M, Ho SH, Hamilton DP. JPPT Clinical investigation utility of anti-Xa monitoring in children receiving enoxaparin for therapeutic anticoagulation. Pediatr Pharmacol. 2005;10(1):43–50.
|
|